A Study of Imvotamab Monotherapy and in Combination in Subjects With Relapsed/Refractory Non-Hodgkin Lymphoma

St. Vincent's Hospital Melbourne, Fitzroy

Monash Health, Clayton

Linear Clinical Resaerch, Nedlands

Hospital Del Mar, Barcelona

NYU, New York

MSKCC, New York

START-Madrid: Fundacion Jimenez Diaz, Madrid

START-Madrid: Centro Integral Oncologico Clara Campal, Madrid

Moffitt Cancer Center, Tampa

Tennessee Oncology, Nashville

Azienda Ospedaliero Universitaria di Bologna-Ematologia Bologna, Bologna

Norton Cancer Institute, Louisville

MD Anderson Cancer Center, Houston

CHU de Poitiers, Poitiers

City of Hope, Duarte

Fred Hutch, Seattle

Dana Farber Cancer Institute (DFCI), Boston

Fakultní nemocnice Královské Vinohrady, Prague

Gustave Roussy, Villejuif

ASST Papa Giovanni XXIII, Bergamo

Fondazione Policlinico Universitario Agostino Gemelli, Roma

Hospital de la Santa Creu i Sant Pau, Barcelona

Institut Catala d'Oncologia, Barcelona

Seoul National University Hospital, Seoul

Samsung Medical Center, Seoul

Hospital Santa Creu i Sant Pau, Barcelona